Bristol-Myers Squibb offers to sell AIDS drugs in Africa at below cost
17 April 2001. Related: Treatment access.
Treatment access
Roche and Trimeris announce US sites and investigators for T-20 phase III study; activists want wider access to drug for sickest AIDS patients
17 April 2001. Related: Antiretrovirals, Treatment access.
European activists demand greater access to T-20
17 April 2001. Related: Treatment access.
From talk to action in fighting AIDS in the developing countries: 8th Retrovirus Conference opening session
17 March 2001. Related: Conference reports, Treatment access.
UNAIDS calls for new deal between pharmaceutical companies and society
17 March 2001. Related: Treatment access.
US trade action threatens Brazilian AIDS programme
17 March 2001. Related: Treatment access.
Brazil may flout trade laws to keep AIDS drugs free for patients
17 March 2001. Related: Treatment access.
Roche open to discuss patent rights of AIDS drug with Brazil
17 March 2001. Related: Treatment access.
Crusading Indian firm takes on might of Glaxo SmithKline: Cipla offers anti-HIV drugs at a fraction of rivals’ prices
17 March 2001. Related: Treatment access.
GSK to review drug pricing policy: pharmaceuticals giant reacts to criticism over costs to poor countries
17 March 2001. Related: Treatment access.
Oxfam launches stinging attack on drug industry over cheap medicines ban
17 March 2001. Related: Treatment access.
Companies weigh offer of royalties for AIDS drugs aimed at Africa
17 March 2001. Related: Treatment access.
Glaxo blocks importation of generic Combivir into Ghana
17 January 2001. Related: Treatment access.
Loans to buy AIDS drugs are rejected by Africans
16 September 2000. Related: Treatment access.
$1bn drug deal creates debt for “tomorrow’s AIDS orphans”
16 August 2000. Related: Treatment access, Other news.